Hims & Hers Health (HIMS) Current Deferred Revenue (2020 - 2026)

Hims & Hers Health has disclosed Current Deferred Revenue across 7 years of filings, most recently posting $165.1 million for Q1 2026.

• Current Deferred Revenue for Q1 2026 came in at $165.1 million, up 49.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $165.1 million (up 49.08% YoY), and the FY2025 annual result was $127.2 million, up 68.87% from the prior year.
• Current Deferred Revenue came in at $165.1 million for Q1 2026 at Hims & Hers Health, up from $127.2 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $165.1 million in Q1 2026 to a low of $1.1 million in Q1 2022.
• The 5-year median for Current Deferred Revenue is $13.7 million (2024), against an average of $46.3 million.
• Across the five-year window, Current Deferred Revenue plunged 53.83% in 2022 and surged 919.92% in 2024, its largest moves.
• Hims & Hers Health's Current Deferred Revenue stood at $1.5 million in 2022, then soared by 425.34% to $7.7 million in 2023, then surged by 873.75% to $75.3 million in 2024, then jumped by 68.87% to $127.2 million in 2025, then increased by 29.86% to $165.1 million in 2026.
• The last three Current Deferred Revenue figures came in at $165.1 million (Q1 2026), $127.2 million (Q4 2025), and $118.5 million (Q3 2025), per Business Quant data.